Senior Medical Science Outcomes Liaison
Akebia Therapeutics
Senior Medical Science Outcomes Liaison
Akebia Therapeutics
Develops CKD anemia therapies
The Medical Science Outcomes Liaison (MSOL) is a field-based Medical Affairs professional responsible for providing scientific, clinical, health outcomes, and population health expertise regionally to key stakeholders across dialysis organizations, nephrology large group practices (LGPs), integrated delivery networks (IDNs), and other healthcare organizations involved in the care of patients with chronic kidney disease (CKD).
The MSOL serves as a Medical Affairs partner to the market access National Accounts team , and is the primary point of engagement for, and collaboration with National Account Managers (NAMs) to support Akebia's strategic account objectives through compliant scientific exchange and medical engagement. The MSOL develops and maintains relationships with regional healthcare decision makers, population health leaders, medical directors, quality leaders, pharmacy stakeholders, nephrology thought leaders, and executive leadership within nephrology large group practices and regional health systems.
Through scientific exchange, the MSOL translates clinical evidence, health economics and outcomes research (HEOR), real-world evidence (RWE), epidemiologic data, and healthcare quality metrics into relevant discussions that support evidence-based decision making and population health initiatives.
The MSOL identifies and communicates emerging trends, evidence gaps, customer insights, and unmet medical needs that inform Medical Affairs, Market Access, Clinical Development, and National Account strategies. In addition to supporting Akebia's commercial portfolio, the MSOL develops strategic scientific relationships with nephrology centers of excellence and key kidney disease experts to support future pipeline readiness initiatives, including rare kidney disease programs.
The MSOL operates as a trusted scientific partner within the healthcare ecosystem while maintaining the independence, objectivity, and compliance standards expected of Medical Affairs.
Essential Functions and Duties
National Account Medical Partnership
Rare Kidney Disease Pipeline Readiness
Essential Functions and Duties
Basic Qualifications
Preferred Qualifications
Knowledge, Skills and Competencies
Base Compensation for this role will depend on a number of factors including a candidate’s qualifications, skills, competencies, and experience, and may fall outside of the range shown. Base pay is only one component of the company’s total rewards package, all regular employees are also eligible for the corporate bonus program or the incentive compensation program (if applicable), as well as equity. Additional benefits include health care, vision, dental, retirement, PTO, etc.
Targeted Base Salary 174680 - 215781 USD
Develops CKD anemia therapies
Akebia Therapeutics focuses on developing and commercializing therapies for chronic kidney disease (CKD), especially anemia related to CKD. Its lead product candidate, vadadustat, is in global Phase 3 trials. The company conducts research, clinical development, and strategic partnerships to bring therapies to market, generating revenue from product sales, licensing, and collaborations. Akebia's goal is to improve the quality of life for CKD patients by providing effective treatments through a science-driven biopharmaceutical approach based in Cambridge, MA.
Explore more opportunities at Akebia Therapeutics